Snowball logo
logo
ZIM_logo

Zimmer Biomet Holdings Inc

€88.54+€0.90  (1.03%)
Estimate
P/E
25.1
EPS
3.53
Beta
0.485
Growth
Revenue, YoY
7.6%
Net income, YoY
33.25%
FCF, YoY
14.14%
Dividends
Dividend yield
0.86%
Annual payout
$0.86
Next ex. div date
December 30, 26
Payout
23.33%
Div.rating
About the company
Ticker
ZIM
ISIN
US98956P1021
Country
United States of America
Sector (GICS)
Healthcare
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Frequently asked questions

What sector does Zimmer Biomet Holdings Inc (ZIM) operate in?

Zimmer Biomet Holdings Inc belongs to the Healthcare sector and operates in the Medical Devices industry.

What is Zimmer Biomet Holdings Inc (ZIM) current stock price?

As of the latest data, Zimmer Biomet Holdings Inc stock price is €88.54, with a previous close of €87.64. Zimmer Biomet Holdings Inc gained €0.90 in the last trading session, representing a 1.03% increase.

What is Zimmer Biomet Holdings Inc (ZIM) current market capitalization?

Zimmer Biomet Holdings Inc market cap is approximately 16.89 billion.

What is Zimmer Biomet Holdings Inc (ZIM) Earnings Per Share (EPS)?

The trailing EPS is €3.53.

What is Zimmer Biomet Holdings Inc (ZIM) Price-to-Earnings (P/E) ratio?

Zimmer Biomet Holdings Inc current P/E ratio is 25.08.

What is Zimmer Biomet Holdings Inc (ZIM) EBITDA?

Zimmer Biomet Holdings Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 524.25 million.

Does Zimmer Biomet Holdings Inc (ZIM) pay dividends?

Yes. Zimmer Biomet Holdings Inc pays quarterly dividends with an annualized yield of 0.86% and an estimated annual payout of €0.86 per share.

When is the next ex-dividend date for Zimmer Biomet Holdings Inc (ZIM)?

The next ex-dividend date is scheduled for December 30, 2026.

When is Zimmer Biomet Holdings Inc (ZIM) next earnings report?

Zimmer Biomet Holdings Inc is expected to release its next earnings report on September 30, 2026.

What is Zimmer Biomet Holdings Inc (ZIM) beta (volatility) score?

Zimmer Biomet Holdings Inc has a beta of 0.485, indicating lower volatility than the overall market.